11-aryl-benzo[B]naphtho[2,3-D]furans and 11-aryl-benzo[B]naphtho

Details 11-aryl-benzo[B]naphtho[2,3-D]furans and 11-aryl-benzo[B]naphtho 11-aryl-benzo[B]naphtho[2,3-D]furans and 11-aryl-benzo[B]naphtho

1999-05-10

2000-08-29

Dentz, Bernard

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514382, 514397, 514414, 514337, 514468, 5462811, 5462841, 548252, 5483114, 548454, 549 6, 549220, 549 42, 549457, A61K 3134, A61K 3138, C07D30777, C07D 3352

Patent

active

061109622

ABSTRACT:
This invention provides compounds of Formula I having the structure ##STR1## wherein A is hydrogen, halogen, or OH;

REFERENCES:
patent: 4808599 (1989-02-01), Dubroeucq et al.
patent: 5698574 (1997-12-01), Riedl et al.
Hastings, John S. et al., J. Chem.Soc., Perkins Trans. 1, 1975, (14), pp. 1839-1842.
Ahmad, F. et al., Biochemica et Biophysica Acta, 1248, 1995, pp. 57-69.
Chang, A.Y. et al., Diabetes, 32, 1983, pp. 830-838.
Coleman, D. L., Diabetologia, 14, 1978, pp. 141-148.
DeFronzo, R. A. et al., Diabetes Care, 14:3, 1991, pp. 173-194.
Goldstein, B. J., Receptor, 3, 1993, pp. 1-15.
Goldstein, B. J. et al., Mol. and Cell. Biochem., 109, 1992, pp. 107-113.
Goldstein, B. J., J. Cell. Biochem., 48, 1992, pp. 33-42.
Haring, H. U., Diabetologia, 34, 1991, pp. 848-861,
Harris, M. I. et al., Diabetes in America, 1985, Chapter 29, pp. 1-48.
Jarrett, R. J., Diabetes/Metabolism Reviews, 5:7, 1989, pp. 547-558.
Lanzetta, P. A. et al., Analytical Biochem. 100, 1979, pp. 95-97.
McGuire, M. C. et al., Diabetes, 40, Jul. 1991, pp. 939-942.
Meyerovitch, J. et al., J. Clin. Invest., 87, Apr. 1991, pp. 1286-1294.
Meyerovitch, J. et al., J. Clin. Invest., 84, Sep. 1989, pp. 976-983.
Mitsunobu, O., Synthesis, Jan. 1981, pp. 1-28.
Nutaitis, C. F., Organic Preparations and Procedures Int., 23(4), 1991, pp. 403-411.
Perich, J. W. et al., Synthesis, Feb. 1988, pp. 142-144.
Phillion, D. P. et al., Tetrahedron, 27:13, 1986, pp. 1477-1480.
Pyorala, K. et al., Diabetes/Metabolism Reviews, 3:2, 1987, pp. 463-524.
Reaven, G. M. et al., Amer. J. Med., 60,1976, pp. 80-88.
Sredy, J. et al., Metabolism, 44:8, 1995, pp. 1074-1081.
Stout, R. W., Metabolism, 34:12 (Suppl 1), Dec. 1985, pp. 7-12.
Zask, A. et al., J. Med. Chem., 33, 1990, pp. 1418-1423.
Chen, H.-M. et al., Indian J. Chem., 35B, Dec. 1996, pp. 1304-1307.
d'Ishia, M. et al., Tetrahedron, 43:2, 1987, pp. 431-434.
Dryhurst, G. et al., J. Am. Chem. Soc., 111, 1989, pp. 719-726.
Guirguis, N. R. et al., J. Prakt. Chemie, 332:3, 1990, pp. 414-418.
Guirguis, N. R. et al., Liebigs Ann. Chem., 1986, pp. 1003-1011.
Han, B. H. et al., Tetrahedron Leter, 31:8, 1990, pp. 1181-1182.
Hashem, A. I., J. Prakt. Chemie, 319:4, 1977, pp. 689-692.
Konopelski, J. P. et al., Synlett, Letters, Jul. 1996, pp. 609-611.
Kuroda, T. et al., J. Org. Chem., 59, 1994, pp. 7353-7357.
Kuroda, T. et al., J. Chem. Soc., Chem. Commun., 1991, pp. 1635-1636.
Lefker, B. A. et al., Tetrahedron Letters, 35:29, 1994, pp. 5205-5208.
Molina, P. et al., Tetrahedron, 50:17, 1994, pp. 5027-5036.
Molina, P. et al., Tetrahedron Letters, 34:17, 1993, pp. 2809-2812.
Napolitano, A. et al., Tetrahedron, 45:21, 1989, pp. 6749-6760.
Schuster, I. I., et al., J. Org. Chem., 53, 1988, pp. 5819-5825.
Kano et al, Heterocycles vol. 19, No. 6, pp. 1033-1037, 1982.

Affiliated with

Also associated with

Rating

11-aryl-benzo[B]naphtho[2,3-D]furans and 11-aryl-benzo[B]naphtho does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 11-aryl-benzo[B]naphtho[2,3-D]furans and 11-aryl-benzo[B]naphtho, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 11-aryl-benzo[B]naphtho[2,3-D]furans and 11-aryl-benzo[B]naphtho will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1250432